Inhibition of vascular adhesion protein‐1 enhances the anti‐tumor effects of immune checkpoint inhibitors - Kinoshita - 2021 - Cancer Science - Wiley Online Library
PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo | Journal of Pharmacology and Experimental Therapeutics
VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation | Arteriosclerosis, Thrombosis, and Vascular Biology
Hypoxia serves a key function in the upregulated expression of vascular adhesion protein‑1 in vitro and in a rat model of hemorrhagic shock
VAP-1: an adhesin and an enzyme: Trends in Immunology
Frontiers | Dysregulation of Leukocyte Trafficking in Type 2 Diabetes: Mechanisms and Potential Therapeutic Avenues
Frontiers | Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases
Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo
PXS-4681A | SSAO/VAP-1 Inhibitor | MedChemExpress
Vascular Adhesion Protein 1 in the Eye
Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment - ScienceDirect
Hepatic consequences of vascular adhesion protein-1 expression | SpringerLink
Functions of VAP-1 in health and disease. VAP1 has multiple different... | Download Scientific Diagram
Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker? - Abstract - Europe PMC
Vascular adhesion protein‐1 blockade suppresses choroidal neovascularization - Noda - 2008 - The FASEB Journal - Wiley Online Library
IJMS | Free Full-Text | SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease
PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo | Journal of Pharmacology and Experimental Therapeutics
VAP-1: an adhesin and an enzyme: Trends in Immunology
JCI - Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis
Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control - ScienceDirect
